PYK2 is overexpressed in chronic lymphocytic leukaemia: A potential new therapeutic target

Chronic Lymphocytic Leukaemia (CLL) is the most common adult B‐cell leukaemia and despite improvement in patients' outcome, following the use of targeted therapies, it remains incurable. CLL supportive microenvironment plays a key role in both CLL progression and drug resistance through signals...

Descripción completa

Detalles Bibliográficos
Autores principales: Sbrana, Francesca Vittoria, Fiordi, Benedetta, Bordini, Jessica, Belloni, Daniela, Barbaglio, Federica, Russo, Luca, Scarfò, Lydia, Ghia, Paolo, Scielzo, Cristina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9930416/
https://www.ncbi.nlm.nih.gov/pubmed/36747338
http://dx.doi.org/10.1111/jcmm.17688

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9930416/
https://www.ncbi.nlm.nih.gov/pubmed/36747338
http://dx.doi.org/10.1111/jcmm.17688

Ejemplares similares